Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease

• Main Authors: Marta Maggisano (Author), Lucrezia Mondini (Author), Maria Chernovsky (Author), Paola Confalonieri (Author), Francesco Salton (Author), Nicolò Reccardini (Author), Metka Kodric (Author), Pietro Geri (Author), Marco Confalonieri (Author), Michael Hughes (Author), Rossella Cifaldi (Author), Barbara Ruaro (Author)
• Format: Bog
• Udgivet: MDPI AG, 2024-08-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Nintedanib, an intracellular inhibitor that targets multiple tyrosine kinase, is an important drug for the treatment of pulmonary fibrosis. Until now, no studies have been published reporting the nintedanib tolerability or its efficacy in patients with chronic pulmonary lung disease and chronic kidn...